chr2-38666196-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138801.3(GALM):āc.35T>Cā(p.Leu12Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000135 in 1,613,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00015 ( 0 hom., cov: 32)
Exomes š: 0.00013 ( 0 hom. )
Consequence
GALM
NM_138801.3 missense
NM_138801.3 missense
Scores
1
11
7
Clinical Significance
Conservation
PhyloP100: 4.91
Genes affected
GALM (HGNC:24063): (galactose mutarotase) This gene encodes an enzyme that catalyzes the epimerization of hexose sugars such as glucose and galactose. The encoded protein is expressed in the cytoplasm and has a preference for galactose. The encoded protein may be required for normal galactose metabolism by maintaining the equilibrium of alpha and beta anomers of galactose.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13718832).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALM | NM_138801.3 | c.35T>C | p.Leu12Pro | missense_variant | 1/7 | ENST00000272252.10 | NP_620156.1 | |
GALM | XM_011532540.3 | c.35T>C | p.Leu12Pro | missense_variant | 1/6 | XP_011530842.1 | ||
GALM | XM_047443419.1 | c.35T>C | p.Leu12Pro | missense_variant | 1/6 | XP_047299375.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALM | ENST00000272252.10 | c.35T>C | p.Leu12Pro | missense_variant | 1/7 | 1 | NM_138801.3 | ENSP00000272252.5 | ||
GALM | ENST00000410063.5 | c.35T>C | p.Leu12Pro | missense_variant | 1/4 | 3 | ENSP00000386233.1 | |||
GALM | ENST00000427858.4 | n.116T>C | non_coding_transcript_exon_variant | 1/4 | 4 | |||||
GALM | ENST00000444351.5 | n.-47T>C | upstream_gene_variant | 5 | ENSP00000409083.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152144Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
23
AN:
152144
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000128 AC: 32AN: 250218Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135276
GnomAD3 exomes
AF:
AC:
32
AN:
250218
Hom.:
AF XY:
AC XY:
14
AN XY:
135276
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000133 AC: 195AN: 1461468Hom.: 0 Cov.: 31 AF XY: 0.000132 AC XY: 96AN XY: 727064
GnomAD4 exome
AF:
AC:
195
AN:
1461468
Hom.:
Cov.:
31
AF XY:
AC XY:
96
AN XY:
727064
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000151 AC: 23AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74432
GnomAD4 genome
AF:
AC:
23
AN:
152264
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
18
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2022 | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 12 of the GALM protein (p.Leu12Pro). This variant is present in population databases (rs201350001, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with GALM-related conditions. ClinVar contains an entry for this variant (Variation ID: 1423840). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Studies have shown that this missense change alters GALM gene expression (PMID: 30910422). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at